Loading…
Based on limited metadata, this FDA Warning Letter issued to Halosense Inc. on March 30, 2020, concerns drug products. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be determined from the available information. The warning falls under FDA's drug regulation authority, though the specific issuing office is not identified in the metadata provided.